# Sumitomo Mitsui Financial Group, Inc. (SMFG)

> Source: Nexqual · https://nexqual.com/SMFG · data as of 2026-10-22 20:00 UTC · cite as "Nexqual, Sumitomo Mitsui Financial Group, Inc. (SMFG), nexqual.com/SMFG" · informational, not investment advice.

**Price:** USD 24.09 (-1.75% on the day) · last close of Oct 22, 2026; US market pre market, not a live price. Prev close 24.52 · day 24.02–24.36 · 52w 15.85–27.62 · market cap $151B · NYQ

## Key facts
- 2 of 80 tracked superinvestors hold SMFG (13F, Q2 2026): 0 new, 2 added, 0 reduced, 0 unchanged.
- Insider open-market sales, last ~7 months: 1 Form 4 filings, $170K; 1 not under a Rule 10b5-1 plan ($170K); 0 by opportunistic insiders, 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Analysts: Buy (mean 2.00 on a 1–5 scale) (1 analysts), mean target USD 15.76 (range 15.76–15.76).
- Total return with dividends: 1Y +51.4% vs S&P 500 +14.9%; 5Y +274.2% vs S&P 500 +80.3%.
- Next earnings: 2026-11-13, EPS estimate USD 0.24, revenue estimate $1.36T.

## Superinvestors (SEC 13F-HR, Q2 2026)
2 of 80 tracked investors hold SMFG. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Sarah Ketterer | Causeway Capital Management | 0.36% | $32.8M | Added +9.9% |
| Richard Pzena | Pzena Investment Management | <0.01% | $880K | Added +14.7% |

## Insider sales (SEC Form 4, open-market, last ~7 months)
0 of 1 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-08-12 | Anchi Kazuyuki | Sr. Mg. Corp. EO & Group CFO | 4,000 | $170K | 7.6% | No | Too little history (no open-market trades in 2023–2025) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.

## Analysts
Consensus Buy (mean 2.00 on a 1–5 scale), 1 analysts; mean target USD 15.76 (low 15.76, high 15.76).

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-23) | 5Y (from 2021-10-18) |
|---|---|---|
| Total return | +51.4% | +274.2% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +51.6% | +30.1% |
| Volatility (annualized) | 29.2% | 30.3% |
| Max drawdown | -20.1% (Feb 2026→Mar 2026) | -27.3% (Jan 2022→Sep 2022) |

## Peers (Banks - Diversified)
UBS (UBS Group AG Registered) USD 46.87 -2.21% · BBVA (Banco Bilbao Vizcaya Argentaria) USD 25.03 -2.95% · SAN (Banco Santander, S.A. Sponsored) USD 12.9 -2.93% · BMO (Bank Of Montreal) USD 170.44 -0.01% · BNS (Bank Nova Scotia Halifax Pfd 3) USD 93.41 -0.63% · TD (Toronto Dominion Bank (The)) USD 125.12 +0.34%

## More
Full page: https://nexqual.com/SMFG · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-09-30) | $0.24 | $0.49 | -50.0% | $1.36T | 1 |
| Next quarter (ends 2026-12-31) | $0.25 | $0.50 | -51.0% | $1.48T | 1 |
| Current fiscal year (ends 2027-03-31) | $0.96 | $1.81 | -47.0% | $5.56T | 1 |
| Next fiscal year (ends 2028-03-31) | $1.09 | $2.03 | -46.1% | $6.14T | 1 |